Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017;51(6):906-920.
doi: 10.1134/S0026893317060048. Epub 2017 Dec 14.

Conformational Fingerprinting Using Monoclonal Antibodies (on the Example of Angiotensin I-Converting Enzyme-ACE)

Affiliations

Conformational Fingerprinting Using Monoclonal Antibodies (on the Example of Angiotensin I-Converting Enzyme-ACE)

S M Danilov. Mol Biol. 2017.

Abstract

During the past 30 years my laboratory has generated 40+ monoclonal antibodies (mAbs) directed to structural and conformational epitopes on human ACE as well as ACE from rats, mice and other species. These mAbs were successfully used for detection and quantification of ACE by ELISA, Western blotting, flow cytometry and immunohistochemistry. In all these applications mainly single mAbs were used. We hypothesized that we can obtain a completely new kind of information about ACE structure and function if we use the whole set of mAbs directed to different epitopes on the ACE molecule. When we finished epitope mapping of all mAbs to ACE (and especially, those recognizing conformational epitopes), we realized that we had obtained a new tool to study ACE. First, we demonstrated that binding of some mAbs is very sensitive to local conformational changes on the ACE surface-due to local denaturation, inactivation, ACE inhibitor or mAbs binding or due to diseases. Second, we were able to detect, localize and characterize several human ACE mutations. And, finally, we established a new concept-conformational fingerprinting of ACE using mAbs that in turn allowed us to obtain evidence for tissue specificity of ACE, which has promising scientific and diagnostic perspectives. The initial goal for the generation of mAbs to ACE 30 years ago was obtaining mAbs to organ-specific endothelial cells, which could be used for organ-specific drug delivery. Our systematic work on characterization of mAbs to numerous epitopes on ACE during these years has lead not only to the generation of the most effective mAbs for specific drug/gene delivery into the lung capillaries, but also to the establishment of the concept of conformational fingerprinting of ACE, which in turn gives a theoretical base for the generation of mAbs, specific for ACE from different organs. We believe that this concept could be applicable for any glycoprotein against which there is a set of mAbs to different epitopes.

Keywords: angiotensin I-converting enzyme; conformation; drug/gene lung targeting; monoclonal antibodies; tissue specificity.

PubMed Disclaimer

References

    1. Köhler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975;256:495–497. doi: 10.1038/256495a0. - DOI - PubMed
    1. http://www.whatisbiotechnology.org/exhibitions/milstein/patents.
    1. Auerbach R., Alby L., Morrissey L.W., et al. Expression of organ-specific antigens on capillary endothelial cells. Microvasc. Res. 1985;29:401–411. doi: 10.1016/0026-2862(85)90028-7. - DOI - PubMed
    1. Allikmets E.Y., Danilov S.M. Mitogen-induced disorganization of capillary-like structures formed by human large vessel endothelial cells in vitro. Tissue Cell. 1986;18:481–489. doi: 10.1016/0040-8166(86)90014-5. - DOI - PubMed
    1. Sturrock E.D., Anthony C.S., Danilov S.M. Peptidyl-dipeptidase A/angiotensin I-converting enzyme. In: Rawlings N.D., Salvesen G., editors. Handbook of Proteolytic Enzymes. 3rd ed. Oxford: Academic Press; 2012. pp. 480–494.

LinkOut - more resources